Cited by 290Retinal Development and DisordersRetinal Diseases and TreatmentsVirus-based gene therapy research

Correction of the retinal dystrophy phenotype of the RCS rat by viral gene transfer of Mertk

Open access
Vollrath, Douglas, Feng, Wei, Duncan, Jacque L., Yasumura, Douglas, D'Cruz, Patricia M., Chappelow, Aimee, Matthes, Michael T., Kay, Mark A. +1 more·2001·Proceedings of the National Academy of Sciences

Abstract

The Royal College of Surgeons (RCS) rat is a widely studied animal model of retinal degeneration in which the inability of the retinal pigment epithelium (RPE) to phagocytize shed photoreceptor outer segments leads to a progressive loss of rod and cone photoreceptors. We recently used positional cloning to demonstrate that the gene Mertk likely corresponds to the retinal dystrophy ( rdy ) locus of the RCS rat. In the present study, we sought to determine whether gene transfer of Mertk to a RCS rat retina would result in correction of the RPE phagocytosis defect and preservation of photoreceptors. We used subretinal injection of a recombinant replication-deficient adenovirus encoding rat Mertk to deliver the gene to the eyes of young RCS rats. Electrophysiological assessment of animals 30 days after injection revealed an increased sensitivity of treated eyes to low-intensity light. Histologic and ultrastructural assessment demonstrated substantial sparing of photoreceptors, preservation of outer segment structure, and correction of the RPE phagocytosis defect in areas surrounding the injection site. Our results provide definitive evidence that mutation of Mertk underlies the RCS retinal dystrophy phenotype, and that the phenotype can be corrected by treatment of juvenile animals. To our knowledge, this is the first demonstration of complementation of both a functional cellular defect (phagocytosis) and a photoreceptor degeneration by gene transfer to the RPE. These results, together with the recent discovery of MERTK mutations in individuals with retinitis pigmentosa, emphasize the importance of the RCS rat as a model for gene therapy of diseases that arise from RPE dysfunction.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.221364198

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 45 references couldn’t be matched to a known paper.

Research works printed but not linked: 13

  1. M Tamai, G J Chader Invest Ophthalmol Visual Sci 18, 913–917 (1979).
  2. M H Chaitin, M O Hall Invest Ophthalmol Visual Sci 24, 812–820 (1983).
  3. M O M Tso, C Zhang, A S Abler, C-J Chang, F Wong, G-Q Chang, T T Lam Invest Ophthalmol Visual Sci 35, 2693–2699 (1994).
  4. W L Herron, B W Riegel, O E Myers, M L Rubin Invest Ophthalmol 8, 595–604 (1969).
  5. M M LaVail, L H Pinto, D Yasumura Invest Ophthalmol Visual Sci 21, 658–668 (1981).
  6. K Valter, J Maslim, F Bowers, J Stone Invest Ophthalmol Visual Sci 39, 2427–2442 (1998).
  7. M M LaVail Invest Ophthalmol Visual Sci 20, 671–675 (1981).
  8. J J Michon, Z L Li, N Shioura, R J Anderson, M O M Tso Invest Ophthalmol Visual Sci 32, 280–284 (1991).
  9. J Bennett, J Wilson, D Sun, B Forbes, A Maguire Invest Ophthalmol Visual Sci 35, 2535–2542 (1994).
  10. T Li, M Adamian, D J Roof, E L Berson, T P Dryja, B J Roessler, B L Davidson Invest Ophthalmol Visual Sci 35, 2543–2549 (1994).
  11. M Akimoto, S Miyatake, J Kogishi, M Hangai, K Okazaki, J C Takahashi, M Saiki, M Iwaki, Y Honda Invest Ophthalmol Visual Sci 40, 273–279 (1999).
  12. R A Bush, K W Hawks, P A Sieving Invest Ophthalmol Visual Sci 36, 2054–2062 (1995).
  13. S Machida, P Chaudhry, T Shinohara, D P Singh, V N Reddy, L T Chylack, P A Sieving, R A Bush Invest Ophthalmol Visual Sci 42, 1087–1095 (2001).

Cited by

Sorted by citations

Authors
Vollrath, D., Feng, W., Duncan, J. L., Yasumura, D., D'Cruz, P. M., Chappelow, A., Matthes, M. T., Kay, M. A., & LaVail, M. M.
Affiliations
University of California, San Francisco (US)
Venue
Proceedings of the National Academy of Sciences
Published
2001-10-09
Volume
98
Issue
22
Pages
12584-12589
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2057314625
Cited by
290
References
45
Citations by year
2026: 5 · 2025: 4 · 2024: 9 · 2023: 5 · 2022: 8 · 2021: 11 · 2020: 10 · 2019: 10 · 2018: 12 · 2017: 12 · 2016: 12 · 2015: 14 · 2014: 11 · 2013: 13 · 2012: 15
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Foundation Fighting Blindness
  • Karl Kirchgessner Foundation
  • Research to Prevent Blindness (EY02162)
  • Macula Vision Research Foundation
  • National Institutes of Health (EY01919, EY00415)
  • National Eye Institute (EY-06842, P30EY002162, EY-01919, R01EY001919, K08EY000415, F32EY006842, R01EY006842)
  • National Institute of Diabetes and Digestive and Kidney Diseases (R01DK049022)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinal Development and Disorders
  • Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
Keywords
MERTK, retinal degeneration, retinal pigment epithelium, photoreceptor outer segment phagocytosis, photoreceptor degeneration, viral gene delivery, adenoviral vector, subretinal injection, complementation, retinitis pigmentosa, gene therapy, RCS rat
MeSH terms
c-Mer Tyrosine Kinase, Adenoviridae, Animals, HeLa Cells, Humans, Phagocytosis, Phenotype, Photoreceptor Cells, Pigment Epithelium of Eye, Proto-Oncogene Proteins, Retinal Diseases, Genetic Therapy, Receptor Protein-Tyrosine Kinases, Gene Transfer, Horizontal, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review